Kang Shin-ho CJ CheilJedang CEO "Proving K-Food Growth Potential... Leap to Global Top Tier"

The 18th Regular Shareholders' Meeting Held

Kang Shin-ho, CEO of CJ CheilJedang, stated on the 25th, "The food business will enhance competitiveness through business structure advancement based on being number one, having an ultra-gap, and a global orientation," adding, "We will prove the growth potential of K-Food with rapid execution and strive to leap into a global top-tier group."

At the 18th regular shareholders' meeting held at the CJ Human Resources Development Center in Jung-gu, Seoul, CEO Kang said in his greeting, "We will strengthen execution capabilities by country for global strategic products to discover opportunities and secure future potential markets," and "Based on differentiated product power, we will continuously secure large-scale products to establish a virtuous cycle of market leadership."

Kang Shin-ho, CEO of CJ CheilJedang, is speaking at the 18th Annual General Meeting of Shareholders held on the 25th at the CJ Human Resources Center in Jung-gu, Seoul. CJ CheilJedang

He emphasized, "Domestically, to focus on online growth, we will promote digital transformation through optimization of online and offline resources and structural innovation, solidifying a sustainable profit structure," and "Overseas, based on K-Food trends, we will establish optimal growth directions by country, strengthen market leadership centered on core businesses in the Americas, and expand infrastructure."

He also added, "In China and Japan, we will pursue business expansion based on a balance of growth and profitability," and "In Europe, Asia-Pacific, and new territories, we will focus on volume growth through mainstream expansion to accelerate the achievement of global business results."

Regarding the bio business, he stated that they will continue to secure resources for profitability-centered growth and future businesses.

CEO Kang explained, "Under the global trend of strengthening protectionism, we will actively utilize global production bases to secure overwhelming total cost competitiveness and solidify the market position of key products," adding, "In the biodegradable plastics business, we will focus on technological capabilities to improve quality and cost, pay attention to accelerating the business, and continuously seek to expand business areas to lay the foundation for future growth engines."

Regarding the Feed & Care business responsible for the feed business, he mentioned, "Based on a quality management system, we will strengthen technical consulting services and increase sales volume by expanding customers and livestock species to improve feed productivity," and "The livestock business will create a business structure resilient to market fluctuations through value chain optimization and establishing a top cost system."

Regarding the human bio business, he said, "We will promote clinical trials and license out of immune oncology new drug projects, continuously expand follow-up pipelines, and accelerate new wellness businesses based on microbiome science," adding, "We will secure differentiated process technologies for the production and supply of advanced new drugs and provide various CDMO services to establish a stable profit base."

Meanwhile, at the regular shareholders' meeting, CJ CheilJedang approved the agenda to reappoint Sohn Kyung-shik, Chairman of CJ Group, as an inside director. Along with this, the agenda items including ▲approval of the 18th financial statements ▲amendment of the articles of incorporation ▲appointment of directors ▲appointment of audit committee members ▲approval of the director remuneration limit were all passed as originally proposed.

This content was produced with the assistance of AI translation services.